Back
Monopar Therapeutics Stock Price Chart
Access Before Tuesday...
Grab your first two primed-to-double trades here.
Sell
39
MNPR
Monopar Therapeutics
Last Price:
$35.90
Seasonality Move:
87.32%
7 Day Trial
ALL ACCESS PASS
$
7
Hurry! Enter these 2 trades by EOD Tuesday
Click here to access your first two trades.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.19 | Sell |
| 20-day SMA: | 42.05 | Sell |
| 50-day SMA: | 38 | Sell |
| 200-day SMA: | 33.13 | Buy |
| 8-day EMA: | 37.52 | Sell |
| 20-day EMA: | 39.56 | Sell |
| 50-day EMA: | 38.97 | Sell |
| 200-day EMA: | 31.7 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.92 | Sell |
| Relative Strength Index (14 RSI): | 42.62 | Sell |
| Chaikin Money Flow: | 31768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.6 - 45.6) | Sell |
| Bollinger Bands (100): | (33.41 - 42.35) | Sell |
Monopar Therapeutics Technical Analysis
| Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 35.90 while MNPR 8-day simple moving average is 38.19, which is a Sell signal.
-
The stock price of MNPR is 35.90 while Monopar Therapeutics 20-day SMA is 42.05, which makes it a Sell.
-
Monopar Therapeutics 50-day simple moving average is 38.00 while MNPR share price is 35.90, making it a Sell technically.
-
MNPR stock price is 35.90 and Monopar Therapeutics 200-day simple moving average is 33.13, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
39
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $35.90. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
219.5M
Price in USD:
35.90
Share Volume:
31.8K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
2.15
Sell
39
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 35.90 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 35.90 while MNPR 8-day exponential moving average is 37.52, which is a Sell signal.
-
The stock price of MNPR is 35.90 while Monopar Therapeutics 20-day EMA is 39.56, which makes it a Sell.
-
Monopar Therapeutics 50-day exponential moving average is 38.97 while MNPR share price is 35.90, making it a Sell technically.
-
MNPR stock price is 35.90 and Monopar Therapeutics 200-day simple moving average is 31.70, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.49 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -0.92, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 42.62, which suggest Monopar Therapeutics is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics is (37.6 - 45.6), which suggest Monopar Therapeutics is a Sell
-
The Bollinger Bands (100) for Monopar Therapeutics is (33.41 - 42.35), which suggest Monopar Therapeutics is a Sell
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.